Karyopharm Therapeutics Inc.KPTINASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank86
3Y CAGR-2.4%
5Y CAGR+6.2%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-2.4%/yr
vs +50.8%/yr prior
5Y CAGR
+6.2%/yr
Recent deceleration
Acceleration
-53.2pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$146.07M+0.6%
2024$145.24M-0.5%
2023$146.03M-7.0%
2022$157.07M-25.1%
2021$209.82M+94.1%
2020$108.08M+164.3%
2019$40.89M+34.8%
2018$30.34M+1790.1%
2017$1.60M+942.2%
2016$154000.00-